Zhengye Biotechnology Holding (ZYBT) Accounts Payables (2023 - 2024)
Zhengye Biotechnology Holding (ZYBT) has disclosed Accounts Payables for 2 consecutive years, with $77403.9 as the latest value for Q4 2024.
- Quarterly Accounts Payables fell 98.78% to $77403.9 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $77403.9 through Dec 2024, down 98.78% year-over-year, with the annual reading at $76000.0 for FY2024, 98.82% down from the prior year.
- Accounts Payables for Q4 2024 was $77403.9 at Zhengye Biotechnology Holding, down from $6.3 million in the prior quarter.
- The five-year high for Accounts Payables was $6.3 million in Q4 2023, with the low at $77403.9 in Q4 2024.